ImmunoCAP Systems. Optimized for allergy testing - Precision - Accuracy - Consistency

Similar documents
Antiphospholipid Syndrome

slge112 Molecular Allergology Product Characteristics ImmunoCAP ISAC slge 112

The first and only fully-automated, multiplexed solution for Measles, Mumps, Rubella and Varicella-zoster virus antibody testing

Bio-Rad Laboratories. Hemoglobin Testing. VARIANT II Hemoglobin Testing System For HbA 1c

ImmunoCAP Tryptase Product information

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link System. Fully-Automated HbA 1c Testing

NEW! KIBION DYNAMIC 13 C BREATH TEST ANALYSER. Rapid and reliable diagnosis of Helicobacter pylori infections

Cardiac Assessment Controls

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link. Fully-Automated HbA 1c Testing

Quantitative Measurement of Emergency Biomarkers in Parallel

HPLC ANALYZER. Gold Standard Accuracy by Ion-Exchange HbA1c. First HPLC Analyzer to Aid in Diagnosis of Diabetes

Infectious Disease Testing. ULTRA Product Line. Safety is not a Matter of Chance

Bio-Rad Laboratories. Cardiac Assessment Controls. Value Assigned for Clinical Laboratory and Point of Care Test Systems

Quantitative Measurement of Cardiac Biomarkers

Cardiac Assessment Controls A critical element of reliable cardiac testing

ILyte TM Automated electrolyte analyzers

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

Results you can trust

CyBio Felix Your Automated Application Starts Here

PRODUCT INFORMATION. New Reagents for Dako CoverStainer. Choose the H&E staining intensity you want.

FinTest IgG4 Screen 20 ELISA KIT

Third Party Controls for Your Dade Behring Systems

Immunohematology. IH-QC Modular System. Select. Combine. Control.

Smart Diagnostics for Point-of-Care!

Global Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd ( Page 1 5/18/2015

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine

Type of panel. Characteristics. Technology

Dako IT S ABOUT TIME. Interpretation Guide. Agilent Pathology Solutions. ALK, ROS1 and RET IQFISH probes (Dako Omnis) MET IQFISH probe (Dako Omnis)

Discover the connection

HRM Series PCB Power Relays

Quality Controls in Allergy Diagnosis

HER2 CISH pharmdx TM Kit Interpretation Guide Breast Cancer

BioPlex 2200 Infectious Disease Panels

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

Guide to Fulfillment of Measurement Uncertainty

SS3 Series. Controlled Avalanche Power Diodes. Features: Mechanical Data: SMC/DO-214AB. Page 1 28/03/06 V1.0

autosamplers ASI-100 and ASI-100T Autosamplers

MyBioSource.com. Instructions for use. Histamine Release

QMS TACROLIMUS APPLICATION BECKMAN COULTER AU480 /AU680 /AU5800

The PATH to better cardiac care starts here

High-Throughput, Cost-Efficient LC-MS/MS Forensic Method for Measuring Buprenorphine and Norbuprenorphine in Urine

METHOD VALIDATION: WHY, HOW AND WHEN?

JOSEFIEN VENDRIK, QUALITY MANAGER IRENE JONGENELEN, COÖRDINATOR CLINICAL SUPPLIES MANAGEMENT/ SENIOR CLINICAL STUDY MANAGER

ab Factor Xa Activity Assay Kit (Fluorometric)

Discover the connection

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

USING THE ACCESS AMH ASSAY IN YOUR LABORATORY

Gentian Canine CRP Immunoassay Application Note for Abbott Architect * c4000

Gentian Canine CRP Immunoassay Application Note for scil VitroVet*

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017

HER103, HER107 Power Diodes - Fast Recovery

Request for Letters of Intent. International Development of H5N1 Influenza Vaccines

for therapeutic drug monitoring

ab HMG-CoA Reductase Activity Assay Kit (Colorimetric)

ImpARAS. Improving Allergy Risk Assessment Strategy for new food proteins. Kitty Verhoeckx, Scientist, TNO, The Netherlands

P6KE Series DO-15. Mechanical Data

BEFLEX CUSTOMER SURVEY 2016

Captus 3000 Thyroid Uptake And Well System The Ultimate... User Friendly... Intuitive

URYXXON 300 Instrumental evaluation of urine test sticks

The Quest for Clinical Relevance

Titan power The best just got better. Impedance, OAE, ABRIS and the revolutionary Wideband Tympanometry in one powerful device

Evaluation of the EUROLYSER-SOLO Total T4 assay. for veterinary samples

TGX and TGX Stain-Free FastCast Acrylamide Kits

SQA-V Gold Semiannual Validation/Proficiency/QC Recommendations

Improving Food Process Control Using the

Titan power The best just got better. Impedance, OAE, ABRIS and the revolutionary Wideband Tympanometry in one powerful device

Mass Spectrometry Made Simple for Clinical Diagnostic Labs

MARKET NEWS for pig meat

BLOOD IS COMPLEX ANALYZING IT SHOULDN T BE DxH 500 * *Not available for sale in the U.S.

POC Testing: The New Standard. InnovaStar From DiaSys.

microprocessor controlled eddy current brake Load / accuracy Watt, speed independent / according to DIN VDE

Polymer Technology Systems, Inc. CardioChek PA Comparison Study

FinTest TM IgG4 Screen 88 ELISA Kit

Alere Technologies GmbH

Monthly measles and rubella monitoring report

Overview of European Consumption Databases

INTERNAL QUALITY CONTROL ( Q I C) QC)

HPV, Cancer and the Vaccination Programme

PRODUCT CATALOG. All products are CE marked

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

ab HIV-1 Protease Inhibitor Screening Kit (Fluorometric)

OPENING UP A NEW WORLD

BÜHLMANN fcal turbo. Calprotectin turbidimetric assay for professional use. Reagent Kit B-KCAL-RSET. Revision date:

Case study examining the impact of German reunification on life expectancy

assay Introduction Conclusions: The D-100 TM system proved to be a robust and reliable method for HbA 1c

PyroMark Q24 CpG MGMT Handbook

Know for sure! Your Power for Health. PapilloCheck and PapilloCheck high-risk HPV-Genotyping: The Clear Edge in Early Detection of Cervical Cancer.

R. Lucassen, 1 J. Schulte-Pelkum, 1 C. Csuvarszki, 2 J. Kleine-Tebbe, 2 M. Fooke, 1 and M. Mahler Material and Methods. 1.

ab HRV 3C Protease Inhibitor Screening Kit (Colorimetric)

Science made smarter. Titan. Advanced made flexible. Impedance, OAE, ABRIS and the revolutionary Wideband Tympanometry in one powerful device

Innovation in Diagnostics. ToRCH. A complete line of kits for an accurate diagnosis INFECTIOUS ID DISEASES

Detection. personal. Now, you can optimize your personal workflow. Promega instruments and reagents integrate easily.

STANDARD OPERATING PROCEDURE TITLE: TOTAL IGE EIA (HYTEC 288)

The analytical phase

Bias in clinical chemistry. Elvar Theodorsson EFLM and Linköping University

Abaxis Piccolo xpress TM

Design and Analysis of a Cancer Prevention Trial: Plans and Results. Matthew Somerville 09 November 2009

Transcription:

ImmunoCAP Systems Optimized for allergy testing - Precision - Accuracy - Consistency 1

The ImmunoCAP systems from Phadia offer an optimal allergy testing solution for every laboratory, regardless of testing volume requirements. From local clinics to the world's largest commercial laboratories From 1 to 30 000 tests per day there is always an ImmunoCAP system designed for your needs. ImmunoCAP systems all offer full automation and the same unrivalled ImmunoCAP technology, still the only technology giving true quantitative IgE measurements. The ImmunoCAP system is the number one choice worlwide for allergy testing both for research and general testing A family to grow with When your allergy testing grows you can simply add new ImmunoCAP instrumentation without having to abandon your previous system. The unique ImmunoCAP Information Data Manager software allows you to integrate several ImmunoCAP systems into one network. without having to learn new software. Main Frame (LIS) ImmunoCAP Information Data Manager Requests (Patient and/or Sample ID) management Quantitative results QC management Instrument monitoring Patient result database Stock management Process monitoring Graphical result reports ImmunoCAP 100 E ImmunoCAP 250 ImmunoCAP 1000 2

Technical features Common system features World-leading ImmunoCAP technology providing accurate and reproducible test results True quantitative measurements Large panel of standardized high-quality allergens and autoimmunity tests ImmunoCAP 100 E Maximum flexibility in the small lab or clinic Fast and automated Single integrated unit Up to 48 different determinations in less than three hours Also for EliA autoimmunity testing Run as stand-alone unit in a local clinic or in a cluster at a larger laboratory Connectable to mainframe Automatic dilution ImmunoCAP 250 Higher capacity and automation for increased productivity Ideal for medium-sized laboratories running 80-400 tests/day Fully automated, continuous random access and mainframe connection Throughput: 60 tests/hour Also for EliA autoimmunity testing Positive identification and full traceability of all samples and reagents All reagents and up to 3 000 tests on-board Up to 6 different methods Automatic sample dilution Stand alone PC hosting the IDM system software Built-in touch screen ImmunoCAP 1000 The optimal solution for the large cost-conscious laboratory to meet the growing need for allergy testing Fully automated, continuous random access and mainframe connection Throughput: 240 tests/hour Positive identification and full traceability of all samples and reagents All reagents and up to 10 000 tests on-board Stand alone PC hosting the IDM system software Built-in touch screen 3

Automation for walk-away productivity The ImmunoCAP systems are all highly automated, requiring minimal hands-on time. Choosing the system with the capacity matching your needs for throughput ensures optimal productivity. Typical work-day schedules for each of the systems are shown below. ImmunoCAP 100 E Load reagents Load Wash / Rinse Load ImmunoCAP Load samples 15-20 minutes Hands-on time Sample process start Maintenance 48 results 10 minutes Start up 8.00 9.00 10.00 11.00 Walk away time ImmunoCAP 250 Load reagents Load Wash / Rinse 10 minutes Load ImmunoCAP Load samples Prime Reagent check 15 minutes Blank reading Hands-on time Automatically done First sample in First result out #100 #200 #250 Close down Start up 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00 Walk away time Auto rinse ImmunoCAP 1000 Load reagents Load Wash / Rinse 15 minutes Load ImmunoCAP Load samples Prime Reagent check 15 minutes Blank reading Hands-on time Automatically done First sample in First result out #400 #800 #1200 Close down 8.00 Start up 9.00 10.00 11.00 12.00 13.00 14.00 15.00 Walk away time Auto rinse 4

ImmunoCAP 100 ImmunoCAP 250 ImmunoCAP 1000 Test/assay 48 250-400 1,200-2,500 Methods/assay 4 6 3 Maximum test N. A. 180+36 600+8 types on-board Test on-board N. A. ~3,000 ~10,000 Sample tube on-board 48 50 200 Sample loading No Yes Yes during assay ImmunoCAP technology Yes Yes Yes EliA technology Yes Yes No Barcode Optional Yes Yes reading samples Barcode Optional Yes Yes reading reagents Foot print 70 x 55cm 127 x 75cm 180 x 100cm Weight 47kg 250kg 700kg Power Supply 100-240V 100-240V 230V 50/60Hz 50-/60Hz 50/60Hz Environmental 18-32 C 18-32 C 18-32 C temperature ImmunoCAP Optional Yes Yes Information Data Manager LIS connection Yes Yes Yes Clustering Yes Yes Yes N. A. = Not Applicable 5

The way to precise and correct IgE measurements The ImmunoCAP systems are developed specifically for allergy testing. The instruments, reagents and test procedures are optimized for the special requirements involved in the task of making precise measurements of IgE antibodies. ImmunoCAP consistently shows better performance than any other allergy test system in independent quality assessment programs like the EuroEQAS allergy program. The precision achieved with ImmunoCAP is in fact comparable to standard clinical chemistry immunoassays, whereas other allergy test methods show considerably higher coefficient of variation (CV). In other words, with other methods the same sample will give varying results at different laboratories and at different points in time and the clinical usefulness of the results will therefore be limited. ImmunoCAP gives precise and reproducible results, regardless of laboratory, operator time, time occasion, lot number, instrument and country. 20 Quality Club Specific IgE Pooled CV (%) during the period Jan '03 - Mar-07 Quality Club is the largest external quality assessment program for allergy testing, with approximately 900 members in 37 countries. This gives the member laboratories the possibility to compare their results with other laboratories world-wide. Quality Club data verify the very low variation in test results, covering all the possible sources of variation, including different laboratories, users, instruments, reagents, and dozens of ImmunoCAP lots. CV (%) 15 10 5 0 Jan-03 Mar-03 May-03 Jul-03 Sep-03 Nov-03 Jan-04 Mar-04 May-04 Jul-04 Sep-04 Nov-04 Jan-05 Mar-05 May-05 Jul-05 Sep-05 Nov-05 Jan-06 Mar-06 May-06 Jul-06 Sep-06 Nov-06 Jan-07 Month ImmunoCAP 100 ImmunoCAP 250 ImmunoCAP 1000 Mar-07 UniCAP 100 fulfils the requirements for the quality assurance of quantitative immunological determinations in medical laboratories and can thus be recommended for quantitative in vitro allergy diagnosis. UniCAP 100 is ergonomic, easy to handle, quick, robust and precise and can be recommended for quantitative in vitro allergy diagnosis. Reference: Investigation of Pharmacia UniCAP 100 for in vitro allergy diagnosis, Clin Lab 1999;45:229-35, Author: Liappis, Lantto, et al. UniCAP is an efficient laboratory system for routine diagnostic testing allergy and a valuable tool for basic studies on allergens and antibodies. In conclusion, the studies verify the diagnostic efficiency of the new generation of ImmunoCAP technology and the automated UniCAP immunoassay system. Reference: Specific IgE antibodies in the diagnosis of atopic disease, Allergy 1998: 53: 763-8, Author: Paganelli, Sastre, Lindholm, et al. The imprecision levels appear satisfactory for UniCAP 100, being within a CV 10 %... The imprecision found in Immulite 2000 for the positive control serum was markedly higher, the CV being in the region of 25 %, a level which appears excessive for this type of determination, and which, for unknown reasons, is much higher than the average found with the same instrument in our laboratory for routine immunochemical determinations ( where the CV ranges from 4 % for tpsa to 11 % for intact PTH ) Reference: In Vitro allergy diagnosis : comparison of a new method of fully automated determination of Specific IgE, using Immulite 2000 compared with UniCAP 100, European Annals of Allergy and Clinical Immunology 2003:Vol 35( 8), Author: G Vignati, E Pastori, S Portalupi, R Temporiti. The truly quantitative allergy test ImmunoCAP is the test system giving results with enough precision to be called truly quantitative. An inferior test system, where the values obtained from the same sample may vary from one test occasion to another, is of course not a reliable tool for following the fine-scale development of IgE sensitization in a patient over time. The ImmunoCAP systems consistently give precise, quantitative results reported in ku A /L. The calibrator is directly traceable and parallell to the WHO reference preparation 75/502 for IgE. Dilution curves shows accurate results for the whole measuring range. 6

CV [%] 20 18 16 14 12 10 8 6 4 2 0 0.2 ImmunoCAP 1000 ImmunoCAP 250 0.3 1 3 10 30 100 IgE antibody concentration [ku A /l] Precision The intra-assay precision (CV%) of ImmunoCAP is as good as standard clinical chemistry immunoassays, which is quite remarkable considering the extremely low concentrations of IgE antibodies found in the serum of even severely allergic patients and the possible interference from immunoglobulins of other classes. Accuracy ImmunoCAP IgE antibody results are truly quantitative and comparable to IgE protein mass units, where 1 U A IgE antibody = 1 IU IgE = 2.42 ng of IgE. ImmunoCAP System [ku /l], 1995 and 2007 A 100 30 10 3 1 ImmunoCAP 100, 1995 ImmunoCAP 250, 2007 Consistency Seventy samples from a clinical trial were first assayed for specific IgE antibodies to eleven allergens in 1987, using Pharmacia CAP System. The samples were stored at - 20 C and eight years later reassayed with ImmunoCAP 100. After 20 years storage the samples were again reassayed, this time using ImmunoCAP 250. The results showed very good agreement; r=0.97 1995/1987 and r=0.99 2007/1987. 0.3 0.1 0.1 0.3 1 3 10 30 100 Pharmacia CAP System [ku A/l], 1987 IgE antibody concentration (ku /l) A 100 10 1 d1-1 d1-2 d1-3 e1-1 e1-2 e1-3 g3-1 g3-2 g3-3 t3-1 t3-2 t3-3 w1-1 w1-2 w1-3 m6-1 m6-2 m6-3 f14-1 f14-2 f14-3 Calibrator, Total IgE Parallelism Parallelism between calibrators and dilutions of sample has been repeatedly verified on the different instruments based on the ImmunoCAP technology. 0.1 0.001 0.01 0.1 1 1/Dilution factor 7

Thirty years of market leadership Phadia developed in vitro allergy testing in the early 1970 s. We were the pioneers in allergy test development and also developed the allergen code standard. Today s ImmunoCAP systems are the result of thirty years of technology, chemistry and instrument development. ImmunoCAP systems are the most frequently used in routine testing and in clinical studies the reference systems in allergy testing. The development history includes several important milestones: 1 st generation 1974 Phadebas RAST 2 nd generation 3 rd generation 4 th generation The first laboratory test for specific IgE-antibodies. The paper disc technology combining quality with a large panel of allergens became the gold standard of allergy testing. 1989 Pharmacia CAP System The ImmunoCAP technology brought new standards of quality and capacity to the market, also introducing semi-automation to increase laboratory efficiency. 1996 UniCAP 100 Introducing full automation and quick assay procedure. Further improvements in precision and reproducibility through improved chemistry, standardized handling and environmental control laid the foundation for truly quantitative measurements. Already 4000 instruments on the market. 2001/2004 ImmunoCAP 1000 and 250 The unsurpassed quality of ImmunoCAP 100 E combined with even higher automation, speed, capacity and continuous random access ability availability. All systems are CE-marked according to 98/79/EC; In vitro diagnostic medical device directive for all EU countries and including Norway and Switzerland. Phadia AB. P O Box 6460, SE-751 37 Uppsala, Sweden Tel +46 18 16 50 00. www.phadia.com Head office Sweden +46 18 16 50 00 Austria +43 1 270 20 20 Belgium +32 2 749 55 15 Brazil +55 11 3345 5050 Denmark +45 7023 3306 Finland +358 9 8520 2560 France +33 1 61 37 34 30 Germany +49 761 47 8050 Great Britain/Ireland +44 1 908 84 70 34 Italy +39 02 641 634 11 Japan +81 3 5365 8332 Netherlands +31 348 494 848 Norway +47 21 67 32 80 Portugal +351 21 423 5350 Spain +34 935 765 800 Sweden +46 18 16 50 00 Switzerland +41 43 343 4050 Taiwan +886 2 2516 0925 United States +1 800 346 4364 Other countries +46 18 16 56 16 52-5108-03/05 RAK Design 2007 8